Rein Therapeutics Inc.
NASDAQRNTX short interest plummets 42.9% in one week to 1.85% of float, driven by sharp deleveraging across the biotech sector as stock falls to $1.13.
Snapshot as of 28 Jun 2026
No long-form analysis yet for RNTX. Pulse alerts and the live data picture are available on ORTEX.
Open RNTX on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RNTX — free to start on ORTEX.
Sign up for free →Open RNTX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live RNTX data →